Improvements in irritability with sertraline versus placebo: Findings from the EMBARC study.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of affective disorders"
DOI: 10.1016/j.jad.2020.06.021
Abstract: BACKGROUND This report seeks to evaluate improvements in symptoms of irritability with sertraline (a selective serotonin reuptake inhibitor antidepressant) versus placebo. METHODS Participants of Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care (EMBARC)… read more here.
Keywords: irritability; irritability sertraline; sertraline placebo; versus placebo ... See more keywords
EEG Biomarkers to Predict Response to Sertraline and Placebo Treatment in Major Depressive Disorder
Sign Up to like & getrecommendations! Published in 2022 at "IEEE Transactions on Biomedical Engineering"
DOI: 10.1109/tbme.2022.3204861
Abstract: Objective: Major depressive disorder (MDD) is a persistent psychiatric condition, and the leading cause of disability, affecting up to 5% of the population worldwide. Antidepressant medications (ADMs) are often the first-line treatment for MDD, but… read more here.
Keywords: response sertraline; treatment; sertraline placebo; sertraline ... See more keywords